Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer
Breast cancer is the most common malignancy in women worldwide, and ovarian cancer is the most lethal gynecological malignancy. Women carrying a BRCA1/2 mutation have a very high lifetime risk of developing breast and ovarian cancer. The only effective risk-reducing strategy in BRCA-mutated women is...
Main Authors: | Maria Luisa Gasparri, Assunta Casorelli, Erlisa Bardhi, Aris Raad Besharat, Delia Savone, Ilary Ruscito, Ammad Ahmad Farooqi, Andrea Papadia, Michael David Mueller, Elisabetta Ferretti, Pierluigi Benedetti Panici |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-04-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317695525 |
Similar Items
-
MicroRNA Modulation by Dietary Supplements in Obesity
by: Tiziana Filardi, et al.
Published: (2020-11-01) -
Pre-microRNA and mature microRNA in human mitochondria.
by: Eric Barrey, et al.
Published: (2011-01-01) -
Rapid generation of microRNA sponges for microRNA inhibition.
by: Joost Kluiver, et al.
Published: (2012-01-01) -
The Clinical and Pathological Profile of BRCA1 Gene Methylated Breast Cancer Women: A Meta-Analysis
by: Ilary Ruscito, et al.
Published: (2021-03-01) -
MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases
by: Mariano Catanesi, et al.
Published: (2020-08-01)